liensinine has been researched along with Cardiotoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceylan, AF; Liang, X; Ren, J; Wang, L; Wang, S; Zhang, Y | 1 |
| Lan, F; Li, M; Li, S; Liu, C; Sun, S; Wang, S; Yu, Y; Zhang, Q | 1 |
2 other study(ies) available for liensinine and Cardiotoxicity
| Article | Year |
|---|---|
Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
Topics: Animals; Apoptosis; Calcium Signaling; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Dynamins; Extracellular Signal-Regulated MAP Kinases; Heart Diseases; Isoquinolines; Mice; Mitochondria, Heart; Mitochondrial Dynamics; Mitophagy; Myocytes, Cardiac; Phenols; Phosphorylation; rab GTP-Binding Proteins; rab7 GTP-Binding Proteins | 2020 |
Liensinine- and Neferine-Induced Cardiotoxicity in Primary Neonatal Rat Cardiomyocytes and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Topics: Animals; Benzylisoquinolines; Cardiotoxicity; Cells, Cultured; Drugs, Chinese Herbal; Female; Humans; Induced Pluripotent Stem Cells; Isoquinolines; Male; Myocytes, Cardiac; Phenols; Rats; Rats, Sprague-Dawley | 2016 |